#pdac — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pdac, aggregated by home.social.
-
“Any attempt to sideline or bypass our member First Nations will not only jeopardize project success but also undermine the legitimacy of the development process itself.”
#Indigenous #FirstNations #PDAC #mining #ONpoli #cdnpoli #investment
-
“Any attempt to sideline or bypass our member First Nations will not only jeopardize project success but also undermine the legitimacy of the development process itself.”
#Indigenous #FirstNations #PDAC #mining #ONpoli #cdnpoli #investment
-
“Any attempt to sideline or bypass our member First Nations will not only jeopardize project success but also undermine the legitimacy of the development process itself.”
#Indigenous #FirstNations #PDAC #mining #ONpoli #cdnpoli #investment
-
“Any attempt to sideline or bypass our member First Nations will not only jeopardize project success but also undermine the legitimacy of the development process itself.”
#Indigenous #FirstNations #PDAC #mining #ONpoli #cdnpoli #investment
-
“Any attempt to sideline or bypass our member First Nations will not only jeopardize project success but also undermine the legitimacy of the development process itself.”
#Indigenous #FirstNations #PDAC #mining #ONpoli #cdnpoli #investment
-
https://www.europesays.com/ie/354197/ Progress toward a blood test for early pancreatic cancer #AminopeptidaseN #ANPEP #Biomarkers #CA199 #CarbohydrateAntigen199 #CD13Antigens #ClinicalCancerResearch #EarlyDetectionOfCancer #Éire #Health #IE #Ireland #KennethZaret #NeoplasmStaging #PancreaticDuctalAdenocarcinoma #PancreaticNeoplasms #PDAC #PIGR #PolymericImmunoglobinReceptor #PolymericImmunoglobulin #THBS2 #Thrombospondin2 #Tumor
-
What a break-through!
Spanish scientists completely cure pancreatic cancer (PDAC) in mice.
The group focused on KRAS, a gene mutated in 90% of people with pancreatic cancer. The team employed a triple therapy, which combined an experimental KRAS inhibitor (daraxonrasib) with an approved drug for certain lung adenocarcinomas (afatinib) and a protein degrader (SD36).
#PDAC #PancreaticCancer #Science #Medicine #Oncology #CancerTreatment
-
What a break-through!
Spanish scientists completely cure pancreatic cancer (PDAC) in mice.
The group focused on KRAS, a gene mutated in 90% of people with pancreatic cancer. The team employed a triple therapy, which combined an experimental KRAS inhibitor (daraxonrasib) with an approved drug for certain lung adenocarcinomas (afatinib) and a protein degrader (SD36).
#PDAC #PancreaticCancer #Science #Medicine #Oncology #CancerTreatment
-
What a break-through!
Spanish scientists completely cure pancreatic cancer (PDAC) in mice.
The group focused on KRAS, a gene mutated in 90% of people with pancreatic cancer. The team employed a triple therapy, which combined an experimental KRAS inhibitor (daraxonrasib) with an approved drug for certain lung adenocarcinomas (afatinib) and a protein degrader (SD36).
#PDAC #PancreaticCancer #Science #Medicine #Oncology #CancerTreatment
-
What a break-through!
Spanish scientists completely cure pancreatic cancer (PDAC) in mice.
The group focused on KRAS, a gene mutated in 90% of people with pancreatic cancer. The team employed a triple therapy, which combined an experimental KRAS inhibitor (daraxonrasib) with an approved drug for certain lung adenocarcinomas (afatinib) and a protein degrader (SD36).
#PDAC #PancreaticCancer #Science #Medicine #Oncology #CancerTreatment
-
What a break-through!
Spanish scientists completely cure pancreatic cancer (PDAC) in mice.
The group focused on KRAS, a gene mutated in 90% of people with pancreatic cancer. The team employed a triple therapy, which combined an experimental KRAS inhibitor (daraxonrasib) with an approved drug for certain lung adenocarcinomas (afatinib) and a protein degrader (SD36).
#PDAC #PancreaticCancer #Science #Medicine #Oncology #CancerTreatment
-
BetaGlue Therapeutics Expands its Clinical Trial in Italy https://www.byteseu.com/1593039/ #BetaGlue #BetaGlueTherapeuticsSpA #IntervantionalRadiology #Italy #Oncology #Pancreas #PDAC #Radiotherapy #SolidTumors #UnresectableSolidTumors #YntraDose
-
After three intensive days of scientific excellence, our course has come to an end. It has been an honor to have such committed and passionate students participating in pancreatic ductal adenocarcinoma (PDAC) research. Thank you to all our students for making this course a resounding success!
See you at the next edition!
#PancreaticCancer #Oncology #MedicalResearch #PDAC #SummerCourse -
After three intensive days of scientific excellence, our course has come to an end. It has been an honor to have such committed and passionate students participating in pancreatic ductal adenocarcinoma (PDAC) research. Thank you to all our students for making this course a resounding success!
See you at the next edition!
#PancreaticCancer #Oncology #MedicalResearch #PDAC #SummerCourse -
After three intensive days of scientific excellence, our course has come to an end. It has been an honor to have such committed and passionate students participating in pancreatic ductal adenocarcinoma (PDAC) research. Thank you to all our students for making this course a resounding success!
See you at the next edition!
#PancreaticCancer #Oncology #MedicalResearch #PDAC #SummerCourse -
After three intensive days of scientific excellence, our course has come to an end. It has been an honor to have such committed and passionate students participating in pancreatic ductal adenocarcinoma (PDAC) research. Thank you to all our students for making this course a resounding success!
See you at the next edition!
#PancreaticCancer #Oncology #MedicalResearch #PDAC #SummerCourse -
After three intensive days of scientific excellence, our course has come to an end. It has been an honor to have such committed and passionate students participating in pancreatic ductal adenocarcinoma (PDAC) research. Thank you to all our students for making this course a resounding success!
See you at the next edition!
#PancreaticCancer #Oncology #MedicalResearch #PDAC #SummerCourse -
@Impossible_PhD I remember reading about Pfizer/BioNTech clinical trials for mRNA vaxx PDAC treatment in 2023, shortly after my mom was diagnosed.
This is immensely important and a huge breakthrough.
Extraordinary work by both BioNTech and MSKCC researchers.https://www.mskcc.org/clinical-updates/custom-mrna-vaccines-pancreatic
-
@Impossible_PhD I remember reading about Pfizer/BioNTech clinical trials for mRNA vaxx PDAC treatment in 2023, shortly after my mom was diagnosed.
This is immensely important and a huge breakthrough.
Extraordinary work by both BioNTech and MSKCC researchers.https://www.mskcc.org/clinical-updates/custom-mrna-vaccines-pancreatic
-
@Impossible_PhD I remember reading about Pfizer/BioNTech clinical trials for mRNA vaxx PDAC treatment in 2023, shortly after my mom was diagnosed.
This is immensely important and a huge breakthrough.
Extraordinary work by both BioNTech and MSKCC researchers.https://www.mskcc.org/clinical-updates/custom-mrna-vaccines-pancreatic
-
@Impossible_PhD I remember reading about Pfizer/BioNTech clinical trials for mRNA vaxx PDAC treatment in 2023, shortly after my mom was diagnosed.
This is immensely important and a huge breakthrough.
Extraordinary work by both BioNTech and MSKCC researchers.https://www.mskcc.org/clinical-updates/custom-mrna-vaccines-pancreatic
-
@Impossible_PhD I remember reading about Pfizer/BioNTech clinical trials for mRNA vaxx PDAC treatment in 2023, shortly after my mom was diagnosed.
This is immensely important and a huge breakthrough.
Extraordinary work by both BioNTech and MSKCC researchers.https://www.mskcc.org/clinical-updates/custom-mrna-vaccines-pancreatic
-
We’re excited to share our latest research: “ELOVL6 as a Therapeutic Target: Disrupting c-MYC-Driven Lipid Metabolism to Enhance Chemotherapy in Pancreatic Cancer.”
https://www.biorxiv.org/content/10.1101/2024.11.11.622928v1
Targeting metabolic dependencies like ELOVL6 in c-MYC-driven cancers could open new avenues in PDAC treatment, offering hope for better patient outcomes. Follow us for updates as we continue exploring the therapeutic potential of lipid metabolism in cancer
-
We’re excited to share our latest research: “ELOVL6 as a Therapeutic Target: Disrupting c-MYC-Driven Lipid Metabolism to Enhance Chemotherapy in Pancreatic Cancer.”
https://www.biorxiv.org/content/10.1101/2024.11.11.622928v1
Targeting metabolic dependencies like ELOVL6 in c-MYC-driven cancers could open new avenues in PDAC treatment, offering hope for better patient outcomes. Follow us for updates as we continue exploring the therapeutic potential of lipid metabolism in cancer
-
We’re excited to share our latest research: “ELOVL6 as a Therapeutic Target: Disrupting c-MYC-Driven Lipid Metabolism to Enhance Chemotherapy in Pancreatic Cancer.”
https://www.biorxiv.org/content/10.1101/2024.11.11.622928v1
Targeting metabolic dependencies like ELOVL6 in c-MYC-driven cancers could open new avenues in PDAC treatment, offering hope for better patient outcomes. Follow us for updates as we continue exploring the therapeutic potential of lipid metabolism in cancer
-
We’re excited to share our latest research: “ELOVL6 as a Therapeutic Target: Disrupting c-MYC-Driven Lipid Metabolism to Enhance Chemotherapy in Pancreatic Cancer.”
https://www.biorxiv.org/content/10.1101/2024.11.11.622928v1
Targeting metabolic dependencies like ELOVL6 in c-MYC-driven cancers could open new avenues in PDAC treatment, offering hope for better patient outcomes. Follow us for updates as we continue exploring the therapeutic potential of lipid metabolism in cancer
-
Today, I gave a lesson on tyrosine kinase receptors and serine/threonine kinase receptors, focusing on their signaling pathways and mutations in cancer. Two notable examples are EGFR and TGFBR. #PDAC
-
Today, I gave a lesson on tyrosine kinase receptors and serine/threonine kinase receptors, focusing on their signaling pathways and mutations in cancer. Two notable examples are EGFR and TGFBR. #PDAC
-
Today, I gave a lesson on tyrosine kinase receptors and serine/threonine kinase receptors, focusing on their signaling pathways and mutations in cancer. Two notable examples are EGFR and TGFBR. #PDAC
-
Today, I gave a lesson on tyrosine kinase receptors and serine/threonine kinase receptors, focusing on their signaling pathways and mutations in cancer. Two notable examples are EGFR and TGFBR. #PDAC
-
Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer #pancreaticcancer #PDAC https://www.nature.com/articles/s41467-024-51534-z
-
Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer #pancreaticcancer #PDAC https://www.nature.com/articles/s41467-024-51534-z
-
Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer #pancreaticcancer #PDAC https://www.nature.com/articles/s41467-024-51534-z
-
#Pancreatic ductal #adenocarcinoma (PDAC) is a deadly #cancer. @RoLiefke &co show that chromatin regulator SAMD1 represses EMT-related genes, inhibiting cellular migration, and is downregulated during #PDAC progression by #E3ligase FBXO11 #PLOSBiology https://plos.io/4crkx94
-
#Pancreatic ductal #adenocarcinoma (PDAC) is a deadly #cancer. @RoLiefke &co show that chromatin regulator SAMD1 represses EMT-related genes, inhibiting cellular migration, and is downregulated during #PDAC progression by #E3ligase FBXO11 #PLOSBiology https://plos.io/4crkx94
-
#Pancreatic ductal #adenocarcinoma (PDAC) is a deadly #cancer. @RoLiefke &co show that chromatin regulator SAMD1 represses EMT-related genes, inhibiting cellular migration, and is downregulated during #PDAC progression by #E3ligase FBXO11 #PLOSBiology https://plos.io/4crkx94
-
#Pancreatic ductal #adenocarcinoma (PDAC) is a deadly #cancer. @RoLiefke &co show that chromatin regulator SAMD1 represses EMT-related genes, inhibiting cellular migration, and is downregulated during #PDAC progression by #E3ligase FBXO11 #PLOSBiology https://plos.io/4crkx94
-
#Pancreatic ductal #adenocarcinoma (PDAC) is a deadly #cancer. @RoLiefke &co show that chromatin regulator SAMD1 represses EMT-related genes, inhibiting cellular migration, and is downregulated during #PDAC progression by #E3ligase FBXO11 #PLOSBiology https://plos.io/4crkx94
-
LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma #pancreaticcancer #PDAC https://www.nature.com/articles/s41418-024-01358-7
-
LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma #pancreaticcancer #PDAC https://www.nature.com/articles/s41418-024-01358-7
-
LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma #pancreaticcancer #PDAC https://www.nature.com/articles/s41418-024-01358-7
-
UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma #pancreaticcancer #PDAC https://www.pnas.org/doi/abs/10.1073/pnas.2401996121?af=R
-
UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma #pancreaticcancer #PDAC https://www.pnas.org/doi/abs/10.1073/pnas.2401996121?af=R
-
UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma #pancreaticcancer #PDAC https://www.pnas.org/doi/abs/10.1073/pnas.2401996121?af=R
-
Hallmarks of pancreatic cancer: spotlight on TAM receptors #pancreaticcancer #PDAC https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00314-1/fulltext?rss=yes
-
Hallmarks of pancreatic cancer: spotlight on TAM receptors #pancreaticcancer #PDAC https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00314-1/fulltext?rss=yes
-
Hallmarks of pancreatic cancer: spotlight on TAM receptors #pancreaticcancer #PDAC https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00314-1/fulltext?rss=yes
-
Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma #PDAC https://www.sciencedirect.com/science/article/pii/S0304383524005573?dgcid=rss_sd_all
-
Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma #PDAC https://www.sciencedirect.com/science/article/pii/S0304383524005573?dgcid=rss_sd_all
-
Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma #PDAC https://www.sciencedirect.com/science/article/pii/S0304383524005573?dgcid=rss_sd_all